Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 1058-1064

  McLean, Peter G ^a   Coupar, Ian M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

5 HT4 receptors; 5 hydroxytryptamine (serotonin); Adenylyl cyclase inhibitor; Cyclic AMP; GR 113808; Human colon; Phosphodiesterase inhibitor; Protein kinase inhibitor

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP; DAU 6236; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; LYASE INHIBITOR; METHYSERGIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ONDANSETRON; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; COLON; HUMAN; HUMAN TISSUE; INTESTINE MUSCLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION;

EID: 0029785502     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15506.x     Document Type: Article

References (50)

1. BEAVO, J.A. (1988). Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv. Second Messenger Phosphoprotein Res., 22, 1-38.
2. BEAVO, J.A. & MUMBY, M.C. (1982). Cyclic AMP-dependent protein phosphorylation. Handb. Exp. Pharmakol., 581, 363-392.
3. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
4. BEEBE, S.J. & CORBIN, J.D. (1986). Cyclic nucleotide-dependent protein kinases. In The Enzymes, vol. XVII. ed. Boyer, P.D. & Krebs, E.G., pp. 43-111. New York: Academic Press.
5. 4) receptors positively coupled to adenylyl cyclase in adult guinea-pig hippocampal membranes; Effect of substituted benzamide derivatives. Mol. Pharmacol., 37, 408-411.
6. BRADFORD, M.M. (1976). A rapid sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of post-junctional 5-hydroxytryptamine (5-HT) receptors mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol., 280, 243.
8. CHENG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
9. CHIJIWA, T., MISHIMA, A., HAGIWARA, M., SANO, M., HAYASHI, K., INOUE, T., NAITO, K., TOSHIOKA, T. & HIDAKA, H. (1989). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
10. COHEN, P. (1978). The role of cyclic AMP-dependent protein kinase in the regulation of glycogen metabolism in mammalian skeletal muscle. Curr. Top. Cell. Regul., 14, 118-196.
11. DUMUIS, A., BOUHELAL, R., SEBBEN, M., CORY, R. & BOCKAERT, J. (1988). A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol., 34, 880-887.
12. 4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedeberg's Arch. Pharmacol., 340, 403-410.
13. + current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br. J. Pharmacol., 105, 973-979.
14. 4 receptors. Eur. J. Pharmacol., 211, 117-120.
15. FRANCIS, S.H., NOBLETT, B.D., TODD, B.W., WELLS, J.N, & CORBIN, J.D. (1988). Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol. Pharmacol., 34, 506-517.
16. FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Catecholamines, Hand. Exp. Pharmacol., vol. 33, ed. Blaschko, H.R. & Muscholl, E. pp. 283-335. Berlin, Heidelberg, New York: Springer-Verlag.
17. 4 receptor. Br. J. Pharmacol., 111, 332-338.
18. 4 receptor: use of a novel antagonist. Br. J. Pharmacol., 108, 106P.
19. HASLAM, R.J., DAVIDSON, M.M.L. & DESJARDINS, J.V. (1978). Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Biochem. J., 176, 83-95.
20. HEI, Y.-J., MACDONELL, K.L., MCNEILL, J.H. & DIAMOND, J. (1991). Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of vas deferens by cyclic AMP analogs. Mol. Pharmacol., 39, 233-238.
21. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-204.
22. 4 receptors by GR 113808. Br. J. Pharmacol., 110, 1172-1174.
23. 4-like receptors in piglet left atrium. Br. J. Pharmacol., 102, 98P.
24. KAUMANN, A.J., SANDERS, L., BROWN, A.M., MURRAY, K.J. & BROWN, M.J. (1990). A 5-hydroxytryptamine receptor in human atrium. Br. J. Pharmacol., 100, 879-885.
25. 4 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 229-236.
26. KREBS, E.G. & BEAVO, J.A. (1979). Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem., 48, 923-959.
27. 4 receptor subtype. Neuroscience, 47, 999-1007.
28. LEFF, P. & DOUGALL, I.G. (1993). Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci., 14, 110-112.
29. LEUNG, E., BLISSARD, D., JETT, M.F. & EGLEN, R.M. (1995). Investigation of the 5-hydroxytryptamine receptor mediating the transient short-circuit current response in guinea-pig ileal mucosa. Naunvn-Schmiedeberg's Arch. Pharmacol., 351, 596-602.
30. LEW, M.J. (1995). Extended concentration-response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges. Br. J. Pharmacol., 115, 745-752.
31. 4 receptor in the guinea-pig ileum. FASEB J. (Suppl. to Atlanta Meeting, April 1991), 5036P.
32. LIPPE, C. & ARDIZZONE, C. (1991). Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenylyl cyclase inhibitors MDL 12330A and SQ 22536. Comp. Biochem. Physiol., 99c, 209-211.
33. LOWE III, J.A. & CHENG, J.B. (1992). The PDE IV family of calcium-independent phosphodiesterase enzymes. Drugs Future, 17, 799.
34. MARLEY, P.D., THOMSON, K.A., JACHNO, K. & JOHNSTON, M.J. (1991). Histamine-induced increases in cyclic AMP levels in bovine adrenal medullary cells. Br. J. Pharmacol., 104, 839-846.
35. 4 receptor antagonist affinities of SB207710, SB205008, and SB203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 132-140.
36. 3 receptor mediating contraction of rat isolated jejunum. Proc. 29th ASCEPT meeting, Dec, 1995, Adelaide, Australia, Ed. Ching, M.S. & Widdop, R.E., p. 139.
37. 4-like receptors in the circular smooth muscle of human colon stimulates cyclic AMP formation. Proc. 29th ASCEPT meeting, Dec, 1995, Adelaide, Australia, ed. Ching, M.S. & Widdop, R.E., p. 67.
38. 4-like receptor in the circular smooth muscle of human colon stimulates cyclic AMP formation. Br. J. Pharmacol., 117, 238-239.
39. 4 receptors in human colon, rat oesophagus and rat ileum. Br. J. Pharmacol., 115, 47-56.
40. MICHAELI, T., BLOOM, T.J., MARTINS, T., LOUGHNEY, K., FERGUSON, K., RIGGS, M., RODGERS, L., BEAVO, J.A. & WIGLER, M. (1993). Isolation and characterization of a previously undetected human cAMPphosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J. Biol. Chem., 268, 12925-12932.
41. MONFERINI, E., GAETANI, P., RODRIGEZ, Y., BAENA, R., PARENTI, M., ZOCCHETTI, A. & RIZZI, C.A. (1993). Pharmacological characterization of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain. Life Sci., 52, PL61-65.
42. NICHOLSON, C.D., CHALLISS, R.A. & SHAHID, M (1991). Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci., 12, 19-27.
43. 4-like receptor in human left atrium. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 382-386.
44. SCHNEIDER, H.H., SCHMIECHEN, R., BREZINSKI, M & SEIDLER, J. (1986). Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur. J. Pharmacol., 127, 105-115.
45. SUTHERLAND, E.W. (1972). Studies on the mechanism of hormone action. Science, 177, 401-408.
46. TAM, F.S.-F., HILLIER, K., BUNCE, K.T. (1994). Characterisation of the 5-Hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br. J. Pharmacol., 113, 143-150.
47. 4-like receptor in human colon circular smooth muscle. Br. J. Pharmacol., 115, 172-176.
48. TONINI, M., MESSORI, E., FRANCESCHETTI, G.P., RIZZI, C.A., CASTOLDI, A.F., COCCINI, T. & CANDURA, S.M. (1994). Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrussor muscle. Br. J. Pharmacol., 113, 1-2.
49. 4 receptor in urinary bladder of rhesus and cynomolgus monkeys. Br. J. Pharmacol., 111, 213-218.
50. WELLS, J.N. & KRAMER, G.L. (1981). Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment. Mol. Cell. Endocrinol., 23, 1-9.